In the clinical setting, we showed that CTEPH patients had higher concentrations of serum HGF in comparison to PTE survivors without evidence of pulmonary hypertension (Fig. 7), although there were no correlation between serum HGF concentration and EC phenotype in vitro described in Figs. 2, 3. The gene discussed is HGF; the disease is chronic thromboembolic pulmonary hypertension.